These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [The tolerability and therapeutic efficacy of rifabutin in the treatment of pulmonary tuberculosis]. Parola D; Dell'Orso D; Giovagnoli S; Bianconi S; Terzano C Recenti Prog Med; 1999 May; 90(5):254-7. PubMed ID: 10380552 [TBL] [Abstract][Full Text] [Related]
10. Rifabutin-associated uveitis in a child. Olesen HH; Krag S Pediatr Infect Dis J; 2005 Nov; 24(11):1023-5. PubMed ID: 16282948 [TBL] [Abstract][Full Text] [Related]
11. A pharmacokinetic study of intermittent rifabutin dosing with a combination of ritonavir and saquinavir in patients infected with human immunodeficiency virus. Gallicano K; Khaliq Y; Carignan G; Tseng A; Walmsley S; Cameron DW Clin Pharmacol Ther; 2001 Aug; 70(2):149-58. PubMed ID: 11503009 [TBL] [Abstract][Full Text] [Related]
12. Rifabutin: where do we stand in 2016? Crabol Y; Catherinot E; Veziris N; Jullien V; Lortholary O J Antimicrob Chemother; 2016 Jul; 71(7):1759-71. PubMed ID: 27009031 [TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infection. Benator DA; Weiner MH; Burman WJ; Vernon AA; Zhao ZA; Khan AE; Jones BE; Sandman L; Engle M; Silva-Trigo C; Hsyu PH; Becker MI; Peloquin CA; Pharmacotherapy; 2007 Jun; 27(6):793-800. PubMed ID: 17542762 [TBL] [Abstract][Full Text] [Related]
14. [Problem of drug-resistant tuberculosis and the way of its solution]. Pukhlik BM Probl Tuberk; 1999; (6):17-20. PubMed ID: 10715949 [TBL] [Abstract][Full Text] [Related]
15. [Infection with Mycobacterium genavense in 2 HIV-seropositive patients in Amsterdam]. Van der Ven AJ; Jacobs JA; Schrey G Ned Tijdschr Geneeskd; 1998 Nov; 142(46):2537-8. PubMed ID: 10028345 [No Abstract] [Full Text] [Related]
16. Hyperpigmentation in a patient with AIDS, receiving rifabutin for disseminated Mycobacterium genavense infection. Figueras C; Garcia L; Bertran JM Eur J Pediatr; 1998 Jul; 157(7):612. PubMed ID: 9686833 [No Abstract] [Full Text] [Related]
18. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS. Cohn DL; Fisher EJ; Peng GT; Hodges JS; Chesnut J; Child CC; Franchino B; Gibert CL; El-Sadr W; Hafner R; Korvick J; Ropka M; Heifets L; Clotfelter J; Munroe D; Horsburgh CR Clin Infect Dis; 1999 Jul; 29(1):125-33. PubMed ID: 10433575 [TBL] [Abstract][Full Text] [Related]
19. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team. Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562 [TBL] [Abstract][Full Text] [Related]
20. Criteria for use of rifabutin in adult patients with human immunodeficiency virus (HIV)-associated disease. Fish N; Kass CL Am J Health Syst Pharm; 1996 Jul; 53(13):1598-9. PubMed ID: 8809283 [No Abstract] [Full Text] [Related] [Next] [New Search]